616 related articles for article (PubMed ID: 16354763)
1. Angiotensin II up-regulates the leukemia-associated Rho guanine nucleotide exchange factor (RhoGEF), a regulator of G protein signaling domain-containing RhoGEF, in vascular smooth muscle cells.
Ying Z; Jin L; Palmer T; Webb RC
Mol Pharmacol; 2006 Mar; 69(3):932-40. PubMed ID: 16354763
[TBL] [Abstract][Full Text] [Related]
2. EphA4-mediated Rho activation via Vsm-RhoGEF expressed specifically in vascular smooth muscle cells.
Ogita H; Kunimoto S; Kamioka Y; Sawa H; Masuda M; Mochizuki N
Circ Res; 2003 Jul; 93(1):23-31. PubMed ID: 12775584
[TBL] [Abstract][Full Text] [Related]
3. Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II.
Ohtsu H; Mifune M; Frank GD; Saito S; Inagami T; Kim-Mitsuyama S; Takuwa Y; Sasaki T; Rothstein JD; Suzuki H; Nakashima H; Woolfolk EA; Motley ED; Eguchi S
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1831-6. PubMed ID: 15994438
[TBL] [Abstract][Full Text] [Related]
4. Ste20-related kinase SLK phosphorylates Ser188 of RhoA to induce vasodilation in response to angiotensin II Type 2 receptor activation.
Guilluy C; Rolli-Derkinderen M; Loufrani L; Bourgé A; Henrion D; Sabourin L; Loirand G; Pacaud P
Circ Res; 2008 May; 102(10):1265-74. PubMed ID: 18420945
[TBL] [Abstract][Full Text] [Related]
5. Essential role for class II phosphoinositide 3-kinase alpha-isoform in Ca2+-induced, Rho- and Rho kinase-dependent regulation of myosin phosphatase and contraction in isolated vascular smooth muscle cells.
Yoshioka K; Sugimoto N; Takuwa N; Takuwa Y
Mol Pharmacol; 2007 Mar; 71(3):912-20. PubMed ID: 17179444
[TBL] [Abstract][Full Text] [Related]
6. Expression and functional role of the RhoA/Rho-kinase pathway in rat coeliac artery.
Teixeira CE; Jin L; Ying Z; Palmer T; Priviero FB; Webb RC
Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):817-24. PubMed ID: 16173942
[TBL] [Abstract][Full Text] [Related]
7. Modular architecture and novel protein-protein interactions regulating the RGS-containing Rho guanine nucleotide exchange factors.
Vázquez-Prado J; Basile J; Gutkind JS
Methods Enzymol; 2004; 390():259-85. PubMed ID: 15488183
[TBL] [Abstract][Full Text] [Related]
8. Regulation of RGS-RhoGEFs by Galpha12 and Galpha13 proteins.
Tanabe S; Kreutz B; Suzuki N; Kozasa T
Methods Enzymol; 2004; 390():285-94. PubMed ID: 15488184
[TBL] [Abstract][Full Text] [Related]
9. Galpha 12 activates Rho GTPase through tyrosine-phosphorylated leukemia-associated RhoGEF.
Suzuki N; Nakamura S; Mano H; Kozasa T
Proc Natl Acad Sci U S A; 2003 Jan; 100(2):733-8. PubMed ID: 12515866
[TBL] [Abstract][Full Text] [Related]
10. Direct interaction of insulin-like growth factor-1 receptor with leukemia-associated RhoGEF.
Taya S; Inagaki N; Sengiku H; Makino H; Iwamatsu A; Urakawa I; Nagao K; Kataoka S; Kaibuchi K
J Cell Biol; 2001 Nov; 155(5):809-20. PubMed ID: 11724822
[TBL] [Abstract][Full Text] [Related]
11. Homo- and hetero-oligomerization of PDZ-RhoGEF, LARG and p115RhoGEF by their C-terminal region regulates their in vivo Rho GEF activity and transforming potential.
Chikumi H; Barac A; Behbahani B; Gao Y; Teramoto H; Zheng Y; Gutkind JS
Oncogene; 2004 Jan; 23(1):233-40. PubMed ID: 14712228
[TBL] [Abstract][Full Text] [Related]
12. Reversible translocation of p115-RhoGEF by G(12/13)-coupled receptors.
Meyer BH; Freuler F; Guerini D; Siehler S
J Cell Biochem; 2008 Aug; 104(5):1660-70. PubMed ID: 18320579
[TBL] [Abstract][Full Text] [Related]
13. Ca2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction.
Sakurada S; Takuwa N; Sugimoto N; Wang Y; Seto M; Sasaki Y; Takuwa Y
Circ Res; 2003 Sep; 93(6):548-56. PubMed ID: 12919947
[TBL] [Abstract][Full Text] [Related]
14. Diguanosine pentaphosphate: an endogenous activator of Rho-kinase possibly involved in blood pressure regulation.
Tölle M; Giebing G; Tietge UJ; Jankowski J; Jankowski V; Henning L; Hörl MP; Weiss W; Zidek W; van der Giet M
J Hypertens; 2006 Oct; 24(10):1991-2000. PubMed ID: 16957559
[TBL] [Abstract][Full Text] [Related]
15. Reduced mRNA and protein content of rho guanine nucleotide exchange factor (RhoGEF) in Bartter's and Gitelman's syndromes: relevance for the pathophysiology of hypertension.
Pagnin E; Semplicini A; Sartori M; Pessina AC; Calò LA
Am J Hypertens; 2005 Sep; 18(9 Pt 1):1200-5. PubMed ID: 16182110
[TBL] [Abstract][Full Text] [Related]
16. Signaling pathways mediating gastrointestinal smooth muscle contraction and MLC20 phosphorylation by motilin receptors.
Huang J; Zhou H; Mahavadi S; Sriwai W; Lyall V; Murthy KS
Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G23-31. PubMed ID: 15591586
[TBL] [Abstract][Full Text] [Related]
17. Critical role of lysine 204 in switch I region of Galpha13 for regulation of p115RhoGEF and leukemia-associated RhoGEF.
Nakamura S; Kreutz B; Tanabe S; Suzuki N; Kozasa T
Mol Pharmacol; 2004 Oct; 66(4):1029-34. PubMed ID: 15258251
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation.
Lassègue B; Alexander RW; Nickenig G; Clark M; Murphy TJ; Griendling KK
Mol Pharmacol; 1995 Oct; 48(4):601-9. PubMed ID: 7476884
[TBL] [Abstract][Full Text] [Related]
19. Opposing roles of endothelial and smooth muscle phosphatidylinositol 3-kinase in vasoconstriction: effects of rho-kinase and hypertension.
Budzyn K; Marley PD; Sobey CG
J Pharmacol Exp Ther; 2005 Jun; 313(3):1248-53. PubMed ID: 15743931
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2.
Wakino S; Hayashi K; Kanda T; Tatematsu S; Homma K; Yoshioka K; Takamatsu I; Saruta T
Circ Res; 2004 Sep; 95(5):e45-55. PubMed ID: 15308580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
